Global Biotech Breakthroughs

Viridian Therapeutics

Market Cap: US$3.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Longeveron

Market Cap: US$13.3m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Precigen

Market Cap: US$1.4b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Noile-Immune Biotech

Market Cap: JP¥6.4b

Researches and develops CAR-T cells for cancer immunotherapies.

GNI Group

Market Cap: JP¥133.8b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Kuros Biosciences

Market Cap: CHF 1.1b

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.5b

Shanghai Rightongene Biotechnology Co., Ltd.

Devyser Diagnostics

Market Cap: SEK 1.9b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Altimmune

Market Cap: US$532.1m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Insmed

Market Cap: US$44.1b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Invivyd

Market Cap: US$529.2m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

Everest Medicines

Market Cap: HK$15.9b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Active Biotech

Market Cap: SEK 71.1m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Oryzon Genomics

Market Cap: €248.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.

Diamyd Medical

Market Cap: SEK 1.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BioRestorative Therapies

Market Cap: US$9.3m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Ardelyx

Market Cap: US$1.3b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Roivant Sciences

Market Cap: US$14.5b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

SELLAS Life Sciences Group

Market Cap: US$220.8m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Unicycive Therapeutics

Market Cap: US$118.6m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

Rezolute

Market Cap: US$905.9m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Rhythm Pharmaceuticals

Market Cap: US$7.3b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Changchun BCHT Biotechnology

Market Cap: CN¥9.0b

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.

Japan Tissue Engineering

Market Cap: JP¥19.7b

Engages in the regenerative medicine business in Japan.

CanSino Biologics

Market Cap: HK$14.1b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

InnoCare Pharma

Market Cap: HK$28.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

CStone Pharmaceuticals

Market Cap: HK$8.3b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

Nanjing Leads Biolabs

Market Cap: HK$10.0b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Captor Therapeutics Spolka Akcyjna

Market Cap: zł298.6m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

Prelude Therapeutics

Market Cap: US$115.4m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Savara

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Cogent Biosciences

Market Cap: US$5.9b

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Zymeworks

Market Cap: US$1.9b

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Ionis Pharmaceuticals

Market Cap: US$12.7b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Creative Medical Technology Holdings

Market Cap: US$10.1m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.